Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $13 | $18 | $7 |
| Short-Term Investments | $31 | $53 | $89 | $140 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $42 | $67 | $109 | $149 |
| Property Plant & Equip (Net) | $3 | $7 | $10 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $7 | $10 | $5 |
| Other Assets | $0 | $0 | -$0 | $0 |
| Total Assets | $45 | $74 | $118 | $153 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $4 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $2 | $2 |
| Total Curr. Liab. | $5 | $6 | $9 | $5 |
| LT Debt | $2 | $4 | $6 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $4 | $6 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $6 | $8 | $2 |
| Total Liabilities | $7 | $9 | $15 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$262 | -$232 | -$198 | -$149 |
| AOCI | -$0 | -$0 | -$1 | -$0 |
| Other Equity | $300 | $297 | $302 | $296 |
| Total Equity | $38 | $65 | $103 | $147 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $74 | $118 | $153 |
| Net Debt | -$6 | -$7 | -$10 | -$5 |